Patient Decision Aid for Antidepressant Use During Pregnancy
Trial Summary
What is the purpose of this trial?
Depression in pregnancy is common, affecting up to 10% of women and represents serious risk to mother and infant. Unfortunately, antidepressant medication, a first-line treatment for depression in pregnancy, also comes with risks, making this a complex decision. Clinical care appears to be insufficient for ensuring that women make decisions that are consistent with their own values and with which they feel satisfied. Patient decision support tools can address such barriers. We have created and piloted with positive results an online patient decision aid (PDA) that has the potential to improve the decision-making process for women regarding antidepressant use in pregnancy in conjunction with clinical care. The overall objective of this study is to conduct a Randomized Controlled Trial (RCT) to assess the efficacy of our PDA for antidepressant use in pregnancy.
Research Team
Simone Vigod
Principal Investigator
Women's College Hospital
Eligibility Criteria
This trial is for women over 18 in Canada who are pregnant or planning to conceive within a year, diagnosed with depression, and deciding whether to start or continue SSRI/SNRI antidepressants. It's not for those with active suicidal thoughts, psychosis, substance abuse issues in the last year, major obstetrical/fetal complications, or inability to complete procedures online/in English.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Electronic Patient Decision Aid (Behavioral Intervention)
- Standard Resource Sheet (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Women's College Hospital
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator